Teva Pharmaceutical Industries Ltd
Close on Oct 19, 2026Market cap $48.13BP/E 68.9Yield –
Teva Pharmaceutical Industries Non-GAAP Diluted EPS Attributable to Teva by Year
Teva Pharmaceutical Industries Non-GAAP Diluted EPS Attributable to Teva: 0.71 $/sh in FY2025, down 29.0% from a year earlier.
Where the FY2025 figure comes from
“|| Non-GAAP diluted EPS attributable to Teva (9) | ($) | 0.96 | 0.71 | ($) | 2.93 | 2.49”
Source: Form 8-K Earnings Release (0001171843-26-000462) ↗
Reported in SEC Form 10-K / Form 10-Q / Form 8-K Earnings Releases.
annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Non-GAAP Diluted EPS Attributable to Teva | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0.71 | -29.0% | Form 8-K Earnings Release (0001171843-26-000462) ↗ |
| FY2024 | Dec 31, 2024 | 1.00 | +40.8% | Form 8-K Earnings Release (0001171843-25-000493) ↗ |
| FY2023 | Dec 31, 2023 | 0.71 | -7.8% | Form 8-K Earnings Release (0001157523-24-000137) ↗ |
| FY2022 | Dec 31, 2022 | 0.77 | +11.6% | Form 8-K Earnings Release (0001157523-23-000205) ↗ |
| FY2021 | Dec 31, 2021 | 0.69 | +9.5% | Form 8-K Earnings Release (0001157523-22-000164) ↗ |
| FY2020 | Dec 31, 2020 | 0.63 | -75.6% | Form 8-K Earnings Release (0001157523-21-000158) ↗ |
| FY2019 | Dec 31, 2019 | 2.58 | – | Form 8-K Earnings Release (0001157523-21-000158) ↗ |
Cite this data
StockData. (2026). Teva Pharmaceutical Industries Non-GAAP Diluted EPS Attributable to Teva, annual FY2019–FY2025 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/ng-diluted-eps
See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.
See a number that looks wrong?